# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-103969
Filing Date
2016-05-20
Accepted
2016-05-20 17:11:18
Documents
6
Period of Report
2016-06-20
Effectiveness Date
2016-05-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | v439550_def14a.htm | DEF 14A | 1544159
2 | GRAPHIC | line.gif | GRAPHIC | 43
3 | GRAPHIC | sig_jcook.jpg | GRAPHIC | 20197
4 | GRAPHIC | spacer.gif | GRAPHIC | 43
5 | GRAPHIC | v439550_proxycard-1.jpg | GRAPHIC | 1085956
6 | GRAPHIC | v439550_proxycard-2.jpg | GRAPHIC | 704665
| Complete submission text file | 0001144204-16-103969.txt |  | 4039554

Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 161667122
SIC: 2836 Biological Products, (No Diagnostic Substances)